EXPAREL

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Estonia, Finland, Ireland, Lithuania, Poland.

Active ingredients

The drug EXPAREL contains one active pharmaceutical ingredient (API):

1	Bupivacaine UNII Y8335394RO - BUPIVACAINE
	Bupivacaine is an amide-type, long-acting local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation.
	Read more about Bupivacaine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EXPAREL Suspension for solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01BB01	Bupivacaine	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1833634, 1833645, 1833656, 1833667, 1833724, 1833735, 1833746, 1833757
FI	Lääkealan turvallisuus- ja kehittämiskeskus	100452, 518135
LT	Valstybinė vaistų kontrolės tarnyba	1091406, 1091407, 1091408, 1091409
PL	Rejestru Produktów Leczniczych	100445874, 100445880
US	FDA, National Drug Code	65250-133, 65250-266